tiprankstipranks
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX

Biodexa Pharmaceuticals (BDRX) Stock Investors

353 Followers
Based on 733,238 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BDRX
On average, investors allocate 0.00% of their portfolios to BDRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 733,238 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BDRX

1.5%
Last 7
Days
8.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BDRX, out of 733,238 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BDRX Investor Activity

No data currently available
Based on the activity of 13,791 investors who made their portfolios public
The table shows changes in BDRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BDRX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AMC Entertainment
5.45%
-0.96%
-5.24%
881.68M
Communication Services
ChargePoint Holdings
4.00%
-1.11%
-4.48%
736.65M
Consumer Cyclical
Riot Platforms
4.99%
-0.62%
+0.25%
2.99B
Financial
Marathon Digital Holdings
5.67%
-0.94%
-2.49%
5.68B
Financial
Blink Charging Co
5.16%
-1.25%
-5.97%
292.87M
Industrials
GE Aerospace
5.51%
+0.35%
+4.78%
184.84B
Industrials
Assertio Therapeutics
2.71%
-1.51%
-6.18%
100.36M
Healthcare
Plug Power
4.95%
-0.98%
-4.79%
1.75B
Industrials
Merck & Company
4.15%
-0.96%
-1.07%
328.13B
Healthcare
XPeng, Inc. ADR
5.31%
-1.10%
-5.14%
7.77B
Consumer Cyclical
Based on the activity of 733,238 active portfolios
Open your Smart Portfolio

BDRX Investor Analysis

BDRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
24.0%
of BDRX holders
are under 35
Average Segment Performance
Average P/E Ratio52.24
Beta6.32
Dividend Yield6.28%
BDRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
56.0%
of BDRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio56.33
Beta11.09
Dividend Yield19.22%
BDRX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
20.0%
of BDRX holders
are over 55
Average Segment Performance
Average P/E Ratio47.15
Beta3.97
Dividend Yield6.60%
Overview of age group and performance of BDRX stock investors
See who invests in BDRX according to age group and performance.

FAQ

How many retail Investors hold BDRX?
<0.1% of TipRanks' retail investors hold BDRX in their portfolios.
    What is BDRX Investor Sentiment?
    BDRX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of BDRX in the last 7 days?
      ▼ 1.5% of TipRanks' retail investors changed their holding of BDRX in the last 7 days.
        What percentage of retail investors changed their holding of BDRX in the last 30 days?
        ▲ 8.7% of TipRanks' retail investors changed their holding of BDRX in the last 30 days.
          What is the average age of retail investors who hold BDRX?
          The average age of BDRX Holders is between 35–55.
            What other stocks have BDRX investors also bought?
            BDRX Investors also bought AMC, CHPT, RIOT, MARA, BLNK, GE, ASRT, PLUG, MRK, XPEV.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CYTKCytokinetics
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis